ArticleCancer immunology research2022

Neoadjuvant Intravenous Oncolytic Vaccinia Virus Therapy Promotes Anticancer Immunity in Patients.

Adel Samson et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.